181 related articles for article (PubMed ID: 23522059)
1. Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma.
Dementyeva E; Kryukov F; Kubiczkova L; Nemec P; Sevcikova S; Ihnatova I; Jarkovsky J; Minarik J; Stefanikova Z; Kuglik P; Hajek R
J Transl Med; 2013 Mar; 11():77. PubMed ID: 23522059
[TBL] [Abstract][Full Text] [Related]
2. Centrosome associated genes pattern for risk sub-stratification in multiple myeloma.
Kryukov F; Nemec P; Radova L; Kryukova E; Okubote S; Minarik J; Stefanikova Z; Pour L; Hajek R
J Transl Med; 2016 May; 14(1):150. PubMed ID: 27234807
[TBL] [Abstract][Full Text] [Related]
3. Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma.
Dementyeva E; Nemec P; Kryukov F; Muthu Raja KR; Smetana J; Zaoralova R; Greslikova H; Kupska R; Kuglik P; Hajek R
Leuk Res; 2010 Aug; 34(8):1007-11. PubMed ID: 20096458
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of 1q21 amplification in patients with multiple myeloma using I-FISH and cIg-FISH].
Yang RF; Li CM; Qiu HR; Lu H; Wu HX; Xu JR; Zhang P; Li JY; Chen LJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):686-9. PubMed ID: 22161106
[TBL] [Abstract][Full Text] [Related]
5. Clinical implication of centrosome amplification in plasma cell neoplasm.
Chng WJ; Ahmann GJ; Henderson K; Santana-Davila R; Greipp PR; Gertz MA; Lacy MQ; Dispenzieri A; Kumar S; Rajkumar SV; Lust JA; Kyle RA; Zeldenrust SR; Hayman SR; Fonseca R
Blood; 2006 May; 107(9):3669-75. PubMed ID: 16373658
[TBL] [Abstract][Full Text] [Related]
6. The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition.
Chng WJ; Braggio E; Mulligan G; Bryant B; Remstein E; Valdez R; Dogan A; Fonseca R
Blood; 2008 Feb; 111(3):1603-9. PubMed ID: 18006703
[TBL] [Abstract][Full Text] [Related]
7. Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors.
Del Rey J; Prat E; Ponsa I; Lloreta J; Gelabert A; Algaba F; Camps J; Miró R
BMC Cancer; 2010 Jun; 10():280. PubMed ID: 20540739
[TBL] [Abstract][Full Text] [Related]
8. Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer.
Denu RA; Zasadil LM; Kanugh C; Laffin J; Weaver BA; Burkard ME
BMC Cancer; 2016 Jan; 16():47. PubMed ID: 26832928
[TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity and centrosome-associated genes in multiple myeloma.
Kryukov F; Nemec P; Dementyeva E; Kubiczkova L; Ihnatova I; Budinska E; Jarkovsky J; Sevcikova S; Kuglik P; Hajek R
Leuk Lymphoma; 2013 Sep; 54(9):1982-8. PubMed ID: 23323949
[TBL] [Abstract][Full Text] [Related]
10. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
[TBL] [Abstract][Full Text] [Related]
11. Modified cIg-FISH protocol for multiple myeloma in routine cytogenetic laboratory practice.
Gole L; Lin A; Chua C; Chng WJ
Cancer Genet; 2014; 207(1-2):31-4. PubMed ID: 24485403
[TBL] [Abstract][Full Text] [Related]
12. Centrosome amplification and clonal evolution in multiple myeloma: Short review.
Kryukova E; Kryukov F; Hajek R
Crit Rev Oncol Hematol; 2016 Feb; 98():116-21. PubMed ID: 26589397
[TBL] [Abstract][Full Text] [Related]
13. PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
Noll JE; Vandyke K; Hewett DR; Mrozik KM; Bala RJ; Williams SA; Kok CH; Zannettino AC
J Hematol Oncol; 2015 Oct; 8():106. PubMed ID: 26445238
[TBL] [Abstract][Full Text] [Related]
14. Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells.
Fiserová A; Hájek R; Holubová V; Büchler T; Sobotka J; Kovárová R; Musilová R; Bourková L; Buliková A; Mareschová I; Janácková Z; Váñová P; Kuglík P; Vorlícek J; Penka M
Neoplasma; 2002; 49(5):300-6. PubMed ID: 12458327
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan.
Huang SY; Yao M; Tang JL; Tsay W; Lee FY; Liu MC; Wang CH; Chen YC; Shen MC; Tien HF
Ann Oncol; 2005 Sep; 16(9):1530-8. PubMed ID: 15939720
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic Immunoglobulin Light Chain Revelation and Interphase Fluorescence In Situ Hybridization in Myeloma.
Moore S; Suttle JM; Nicola M
Methods Mol Biol; 2017; 1541():127-142. PubMed ID: 27910020
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
18. Cohort analysis of FISH testing of CD138(+) cells in relapsed multiple myeloma: implications for prognosis and choice of therapy.
Smith D; Stephenson C; Percy L; Lach A; Chatters S; Kempski H; Yong K
Br J Haematol; 2015 Dec; 171(5):881-3. PubMed ID: 25899469
[No Abstract] [Full Text] [Related]
19. Visualization of numerical centrosomal abnormalities by immunofluorescent staining.
Kryukov F; Dementyeva E; Kuglík P; Hájek R
Klin Onkol; 2011; 24 Suppl():S49-52. PubMed ID: 21923065
[TBL] [Abstract][Full Text] [Related]
20. Induction of centrosome amplification and chromosome instability in p53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE).
Shinmura K; Iwaizumi M; Igarashi H; Nagura K; Yamada H; Suzuki M; Fukasawa K; Sugimura H
J Pathol; 2008 Nov; 216(3):365-74. PubMed ID: 18788085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
